[HTML][HTML] Inflammatory bowel disease and primary sclerosing cholangitis: One disease or two?
KN van Munster, A Bergquist, CY Ponsioen - Journal of Hepatology, 2023 - Elsevier
Primary sclerosing cholangitis (PSC) was declared one of the biggest unmet needs in
hepatology during ILC 2016 in Berlin. Since then, not much has changed unfortunately …
hepatology during ILC 2016 in Berlin. Since then, not much has changed unfortunately …
Role of microbiome in autoimmune liver diseases
The microbiome plays a crucial role in integrating environmental factors into host
physiology, potentially linking it to autoimmune liver diseases, such as autoimmune …
physiology, potentially linking it to autoimmune liver diseases, such as autoimmune …
Patient‐reported quality of care in primary sclerosing cholangitis
M Walmsley, D Tornai, N Cazzagon… - Liver …, 2023 - Wiley Online Library
Background Management and follow‐up strategies for primary sclerosing cholangitis (PSC)
vary. The aim of the present study was to assess patient‐reported quality of care to identify …
vary. The aim of the present study was to assess patient‐reported quality of care to identify …
[HTML][HTML] Liver transplant in patients with primary sclerosing cholangitis: a retrospective cohort from Northeastern Brazil
LT de Souza Freitas, EB Hyppolito… - World Journal of …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Primary sclerosing cholangitis (PSC) manifests within a broad ethnic and
racial spectrum, reflecting different levels of access to health care. AIM To evaluate the …
racial spectrum, reflecting different levels of access to health care. AIM To evaluate the …
Risk Assessment and Cholangiocarcinoma: Diagnostic Management and Artificial Intelligence
Simple Summary The only curative treatment for intrahepatic cholangiocarcinoma (iCCA) is
surgical resection, and an early diagnosis is the most effective way to improve survival. In …
surgical resection, and an early diagnosis is the most effective way to improve survival. In …
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics
The gut microbiome is acknowledged as a key determinant of human health, and
technological progress in the past two decades has enabled the deciphering of its …
technological progress in the past two decades has enabled the deciphering of its …
Primär sklerosierende Cholangitis–Diagnose und Therapie 2024
M Trauner, E Halilbasic, E Tatscher, P Fickert - Die Innere Medizin, 2024 - Springer
Die Ursache der primär sklerosierenden Cholangitis (PSC) bleibt unklar und erklärt das
Fehlen einer kausalen Therapie. Die differenzialdiagnostische Abgrenzung zur noch …
Fehlen einer kausalen Therapie. Die differenzialdiagnostische Abgrenzung zur noch …
[HTML][HTML] Setting up an integrated service for PSC-IBD patients: A quality improvement project
S Kotha, I Koumoutsos, B Warner, E Theocharidou… - iLIVER, 2024 - Elsevier
Background and aims Primary sclerosing cholangitis (PSC) often co-exists with inflammatory
bowel disease (IBD) and together they are associated with increased risk of complications …
bowel disease (IBD) and together they are associated with increased risk of complications …
Update: primär biliäre Cholangitis, primär sklerosierende Cholangitis und IgG4-assoziierte Cholangitis
JP Weltzsch, M Sebode, J Hartl - Die Gastroenterologie, 2023 - Springer
Zusammenfassung Hintergrund Cholestatische Lebererkrankungen führen unbehandelt zur
Leberzirrhose mit lebensbedrohlichen Komplikationen bzw. zur Notwendigkeit einer …
Leberzirrhose mit lebensbedrohlichen Komplikationen bzw. zur Notwendigkeit einer …
Primary sclerosing cholangitis-Diagnosis and treatment 2024
M Trauner, E Halilbasic, E Tatscher… - Innere Medizin …, 2024 - europepmc.org
Die Ursache der primär sklerosierenden Cholangitis (PSC) bleibt unklar und erklärt das
Fehlen einer kausalen Therapie. Die differenzialdiagnostische Abgrenzung zur noch …
Fehlen einer kausalen Therapie. Die differenzialdiagnostische Abgrenzung zur noch …